BVI Stock Analysis: Bureau Veritas | PA
Consulting Services | PA, France | Market Cap: 13.366m EUR | 12M Return: 9.8% | FR0006174348 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.1M
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Bureau Veritas SA is a France-based Testing, Inspection, and Certification (TIC) company headquartered in Neuilly-sur-Seine, founded in 1828 and listed on the Paris exchange under the ticker BVI. It operates through six reporting segments - Marine & Offshore; Agri-Food & Commodities; Industry; Buildings & Infrastructure; Certification; and Consumer Products - providing inspection, analysis, auditing, certification, and laboratory testing services for products, assets, and management systems against regulatory or voluntary standards.
The company serves a broad range of end markets, including construction and civil engineering, real estate, transportation, oil and gas, marine and offshore, nuclear, defense, automotive, aerospace, power and utilities, consumer products, retail, financial services, and the public sector. It operates in approximately 140 countries through a global network of offices and laboratories. Bureau Veritas is generally regarded as one of the leading global players in the TIC industry, alongside peers such as SGS, Intertek, and TÜV Rheinland. Demand for TIC services is typically driven by regulatory compliance requirements, supply chain globalization, and the increasing complexity of quality, safety, and sustainability standards across industries.
- Marine & Offshore spending tied to oil prices and shipping cycles
- Buildings & Infrastructure inspection demand driven by construction and energy transition
- Certification segment benefits from tightening global regulatory standards
| Net Income: 503.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.86 > 1.0 |
| NWC/Revenue: 6.71% < 20% (prev 6.78%; Δ -0.07% < -1%) |
| CFO/TA 0.14 > 3% & CFO 960.2m > Net Income 503.6m |
| Net Debt (2.51b) to EBITDA (1.18b): 2.13 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (448.9m) vs 12m ago -1.51% < -2% |
| Gross Margin: 19.91% > 18% (prev 73.82%; Δ -53.91% > 0.5%) |
| Asset Turnover: 96.41% > 50% (prev 97.76%; Δ -1.35% > 0%) |
| Interest Coverage Ratio: 7.23 > 6 (EBIT TTM 875.9m / Interest Expense TTM 121.1m) |
| A: 0.06 (Total Current Assets 3.04b - Total Current Liabilities 2.60b) / Total Assets 6.99b |
| B: 0.23 (Retained Earnings 1.60b / Total Assets 6.99b) |
| C: 0.13 (EBIT TTM 875.9m / Avg Total Assets 6.78b) |
| D: 0.31 (Book Value of Equity 1.66b / Total Liabilities 5.29b) |
| Altman-Z'' = 2.36 = BBB |
| DSRI: 1.01 (Receivables 2.08b/2.03b, Revenue 6.53b/6.41b) |
| GMI: 3.71 (GM 73.82% / 19.91%) |
| AQI: 1.06 (AQ_t 0.46 / AQ_t-1 0.43) |
| SGI: 1.02 (Revenue 6.53b / 6.41b) |
| TATA: -0.07 (NI 503.6m - CFO 960.2m) / TA 6.99b) |
| Beneish M = -0.52 (Cap -4..+1) = D |
As of November 12, 2026, the stock is trading at EUR 30.05 with a total of 955,207 shares traded. Over the past week, the price has changed by +0.50%, over one month by +10.36%, over three months by +6.83% and over the past year by +9.77%.
Current recommended Stop Loss: 28.80 (which is 4.2% or 2.6 ATR below the current price).
Bureau Veritas has no consensus analysts rating.
P/E Trailing = 26.9821
P/E Forward = 17.8891
P/S = 1.9807
P/B = 7.7761
P/EG = 2.2927
Revenue TTM = 6.53b EUR
EBIT TTM = 875.9m EUR
EBITDA TTM = 1.18b EUR
Long Term Debt = 1.89b EUR (from longTermDebt, last quarter)
Short Term Debt = 862.0m EUR (from shortTermDebt, last quarter)
Debt = 3.45b EUR (from shortLongTermDebtTotal, last quarter) + Leases 411.1m
Net Debt = 2.51b EUR (calculated: Debt 3.45b - CCE 942.1m)
Enterprise Value = 15.9b EUR (13.4b + Debt 3.45b - CCE 942.1m)
Interest Coverage Ratio = 7.23 (Ebit TTM 875.9m / Interest Expense TTM 121.1m)
EV/FCF = 19.62x (Enterprise Value 15.9b / FCF TTM 809.2m)
FCF Yield = 5.10% (FCF TTM 809.2m / Enterprise Value 15.9b)
FCF Margin = 12.39% (FCF TTM 809.2m / Revenue TTM 6.53b)
Net Margin = 7.71% (Net Income TTM 503.6m / Revenue TTM 6.53b)
Gross Margin = 19.91% ((Revenue TTM 6.53b - Cost of Revenue TTM 5.23b) / Revenue TTM)
Gross Margin QoQ = 15.19% (prev 24.61%)
Tobins Q-Ratio = 2.27 (Enterprise Value 15.9b / Total Assets 6.99b)
Interest Expense / Debt = 3.51% (Interest Expense 121.1m / Debt 3.45b)
Taxrate = 33.97% (269.5m / 793.3m)
NOPAT = 578.3m (EBIT 875.9m * (1 - 33.97%))
Current Ratio = 1.17 (Total Current Assets 3.04b / Total Current Liabilities 2.60b)
Debt / Equity = 2.08 (Debt 3.45b / totalStockholderEquity, last quarter 1.66b)
Debt / EBITDA = 2.13 (Net Debt 2.51b / EBITDA 1.18b)
Debt / FCF = 3.10 (Net Debt 2.51b / FCF TTM 809.2m)
Total Stockholder Equity = 1.70b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.43% (Net Income 503.6m / Total Assets 6.99b)
RoE = 29.70% (Net Income TTM 503.6m / Total Stockholder Equity 1.70b)
RoCE = 24.42% (EBIT 875.9m / Capital Employed (Equity 1.70b + L.T.Debt 1.89b))
RoIC = 11.73% (NOPAT 578.3m / Invested Capital 4.93b)
WACC = 5.41% (E(13.4b)/V(16.8b) * Re(6.21%) + D(3.45b)/V(16.8b) * Rd(3.51%) * (1-Tc(0.34)))
Discount Rate = 6.21% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -79.96 | Cagr: -0.72%
[DCF] Terminal Value 75.34% ; FCFF base≈811.6m ; Y1≈809.9m ; Y5≈847.3m
[DCF] Fair Price = 24.16 (EV 13.2b - Net Debt 2.51b = Equity 10.7b / Shares 442.3m; r=8.35% [WACC [floored]]; 5y FCF grow -0.75% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 94.65 | Revenue CAGR: 4.28% | SUE: 1.12 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=1.50 | Chg30d=-2.91% | Revisions=+0% | GrowthEPS=+5.6% | GrowthRev=+1.1%
EPS next Year (2027-12-31): EPS=1.62 | Chg30d=-0.45% | Revisions=+70% | GrowthEPS=+8.3% | GrowthRev=+5.7%
[Analyst] Revisions Ratio: +44% (up=10, down=3)